pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

18,994 catalysts · 18,987 approval · 7,208 phase readout · 5,000 device 510k · 4,728 grant · 3,603 8k filing · 2,000 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 1 catalyst2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts2026-11-16: 0 catalysts2026-11-17: 0 catalysts2026-11-18: 0 catalysts2026-11-19: 0 catalysts2026-11-20: 0 catalysts2026-11-21: 0 catalysts2026-11-22: 0 catalysts
view
agendamonth
hide past →
sort
soonestlatesttypesponsoralpha
type: approval×type: pdufa×clear all
type
  • approval18,987
  • phase readout7,208
  • device 510k5,000
  • grant4,728
  • 8k filing3,603
  • device pma2,000
  • device recall
2,000
  • recall1,126
  • device adverse event1,000
  • earnings585
  • therapy area
    • Dermatology1
    • Infectious Disease1

    Week of Feb 9, 2026

    50
    ›Feb 9, 2026approval202d agoISOTRETINOIN — FDA approvalSun Pharmaceutical Industries Ltd

    Sponsor: ACTAVIS LABS FL. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 9, 2026approval202d agoSCOPOLAMINE — FDA approvalRiconpharma LLC

    Sponsor: PADAGIS US. Form: SYSTEM. Route: TRANSDERMAL

    full page →fda approvals ↗
    ›Feb 9, 2026approval202d agoSCOPOLAMINE — FDA approvalRiconpharma LLC

    Sponsor: PADAGIS US. Form: SYSTEM. Route: TRANSDERMAL

    full page →fda approvals ↗
    ›Feb 9, 2026approval202d agoMYORISAN (ISOTRETINOIN) — FDA approvalSun Pharmaceutical Industries Ltd

    Sponsor: UPSHER SMITH LABS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 9, 2026approval202d agoDIGOXIN — FDA approvalHikma Pharmaceuticals USA Inc

    Sponsor: IMPAX LABS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 9, 2026approval202d agoOLANZAPINE — FDA approvalolanzapine ODT

    Sponsor: DR REDDYS LABS LTD. Form: TABLET. Route: ORAL

    full page →olanzapine ODT →fda approvals ↗
    ›Feb 9, 2026approval202d agoCLARAVIS (ISOTRETINOIN) — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA PHARMS USA. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 9, 2026approval202d agoISOTRETINOIN — FDA approvalSun Pharmaceutical Industries Ltd

    Sponsor: AMNEAL PHARMS NY. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 9, 2026approval202d agoISOTRETINOIN — FDA approvalSun Pharmaceutical Industries Ltd

    Sponsor: UPSHER SMITH LABS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 9, 2026approval202d agoOLANZAPINE — FDA approvalolanzapine ODT

    Sponsor: DR REDDYS LABS LTD. Form: TABLET. Route: ORAL

    full page →olanzapine ODT →fda approvals ↗
    ›Feb 9, 2026approval202d agoGIMOTI (METOCLOPRAMIDE HYDROCHLORIDE) — FDA approvalEvoke Pharma Inc

    Sponsor: QOL MEDCL. Form: SPRAY, METERED. Route: NASAL

    full page →fda approvals ↗
    ›Feb 9, 2026approval202d agoABSORICA (ISOTRETINOIN) — FDA approvalSun Pharmaceutical Industries Ltd

    Sponsor: SUN PHARM INDS INC. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 9, 2026approval202d agoISOTRETINOIN — FDA approvalZydus Therapeutics Inc

    Sponsor: ZYDUS PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 9, 2026approval202d agoAMNESTEEM (ISOTRETINOIN) — FDA approvalMylan Pharmaceuticals Inc

    Sponsor: MYLAN PHARMS INC. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 9, 2026approval202d agoTRAZODONE HYDROCHLORIDE — FDA approvalTRAZODONE HYDROCHLORIDE

    Sponsor: APOTEX INC. Form: TABLET. Route: ORAL

    full page →TRAZODONE HYDROCHLORIDE →fda approvals ↗
    ›Feb 9, 2026approval202d agoMETHAZOLAMIDE — FDA approvalMETHAZOLAMIDE

    Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL

    full page →METHAZOLAMIDE →fda approvals ↗
    ›Feb 9, 2026approval202d agoREGLAN (METOCLOPRAMIDE HYDROCHLORIDE) — FDA approvalmetoclopramide hydrochloride

    Sponsor: HIKMA. Form: INJECTABLE. Route: INJECTION

    full page →metoclopramide hydrochloride →fda approvals ↗
    ›Feb 9, 2026approval202d agoCLARAVIS (ISOTRETINOIN) — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA PHARMS USA. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 9, 2026approval202d agoISOTRETINOIN — FDA approvalZydus Therapeutics Inc

    Sponsor: ZYDUS PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 9, 2026approval202d agoABSORICA LD (ISOTRETINOIN) — FDA approvalSun Pharmaceutical Industries Ltd

    Sponsor: SUN PHARM. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 9, 2026approval202d agoTRAZODONE HYDROCHLORIDE — FDA approvalTRAZODONE HYDROCHLORIDE

    Sponsor: APOTEX. Form: TABLET. Route: ORAL

    full page →TRAZODONE HYDROCHLORIDE →fda approvals ↗
    ›Feb 9, 2026approval202d agoISOTRETINOIN — FDA approvalSun Pharmaceutical Industries Ltd

    Sponsor: UPSHER SMITH LABS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 9, 2026approval202d agoSCOPOLAMINE — FDA approvalscopolamine ER

    Sponsor: RICONPHARMA LLC. Form: SYSTEM. Route: TRANSDERMAL

    full page →scopolamine ER →fda approvals ↗
    ›Feb 9, 2026approval202d agoSCOPOLAMINE — FDA approvalscopolamine ER

    Sponsor: RICONPHARMA LLC. Form: SYSTEM. Route: TRANSDERMAL

    full page →scopolamine ER →fda approvals ↗
    ›Feb 9, 2026approval202d agoSCOPOLAMINE — FDA approvalscopolamine ER

    Sponsor: RICONPHARMA LLC. Form: SYSTEM. Route: TRANSDERMAL

    full page →scopolamine ER →fda approvals ↗
    ›Feb 9, 2026approval202d agoISOTRETINOIN — FDA approvalSun Pharmaceutical Industries Ltd

    Sponsor: AMNEAL PHARMS NY. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 9, 2026approval202d agoISOTRETINOIN — FDA approvalISOTRETINOIN

    Sponsor: AUROBINDO PHARMA. Form: CAPSULE. Route: ORAL

    full page →ISOTRETINOIN →fda approvals ↗
    ›Feb 9, 2026approval202d agoZENATANE (ISOTRETINOIN) — FDA approvalISOTRETINOIN

    Sponsor: DR REDDYS LABS LTD. Form: CAPSULE. Route: ORAL

    full page →ISOTRETINOIN →fda approvals ↗
    ›Feb 9, 2026approval202d agoLIDOCAINE — FDA approvalLIDOCAINE

    Sponsor: USPHARMA. Form: PATCH. Route: TOPICAL

    full page →LIDOCAINE →fda approvals ↗
    ›Feb 9, 2026approval202d agoDIGOXIN — FDA approvalDIGOXIN

    Sponsor: RISING. Form: TABLET. Route: ORAL

    full page →DIGOXIN →fda approvals ↗
    ›Feb 10, 2026approval201d agoKEYTRUDA (PEMBROLIZUMAB) — FDA approvalpembrolizumab

    Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS

    full page →pembrolizumab →fda approvals ↗
    ›Feb 10, 2026approval201d agoKEYTRUDA QLEX (PEMBROLIZUMAB) — FDA approval(berahyaluronidase alfa + pembrolizumab)

    Sponsor: MERCK SHARP DOHME. Form: INJECTABLE. Route: INJECTION

    full page →(berahyaluronidase alfa + pembrolizumab) →fda approvals ↗
    ›Feb 10, 2026approval201d agoEVRYSDI (RISDIPLAM) — FDA approvalEVRYSDI

    Sponsor: GENENTECH INC. Form: TABLET. Route: ORAL

    full page →EVRYSDI →fda approvals ↗
    ›Feb 10, 2026approval201d agoEVRYSDI (RISDIPLAM) — FDA approvalEVRYSDI

    Sponsor: GENENTECH INC. Form: FOR SOLUTION. Route: ORAL

    full page →EVRYSDI →fda approvals ↗
    ›Feb 10, 2026approval201d agoFLUDROCORTISONE ACETATE — FDA approvalNovitium Pharma LLC

    Sponsor: HIBROW HLTHCARE. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 10, 2026approval201d agoTRETINOIN — FDA approvalMylan Pharmaceuticals Inc

    Sponsor: ENCUBE. Form: CREAM. Route: TOPICAL

    full page →fda approvals ↗
    ›Feb 10, 2026approval201d agoFLUOROURACIL — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA PHARMS USA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Feb 10, 2026approval201d agoFLUOROURACIL — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA PHARMS USA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Feb 10, 2026approval201d agoSULFAMETHOXAZOLE AND TRIMETHOPRIM (SULFAMETHOXAZOLE) — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA PHARMS USA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Feb 10, 2026approval201d agoGLYCOPYRROLATE — FDA approvalGLYCOPYRROLATE

    Sponsor: RISING. Form: TABLET. Route: ORAL

    full page →GLYCOPYRROLATE →fda approvals ↗
    ›Feb 10, 2026approval201d agoTAPENTADOL HYDROCHLORIDE — FDA approvaltapentadol hydrochloride ER

    Sponsor: HIKMA. Form: TABLET. Route: ORAL

    full page →tapentadol hydrochloride ER →fda approvals ↗
    ›Feb 11, 2026approval200d agoGLATIRAMER ACETATE — FDA approvalGLATIRAMER ACETATE

    Sponsor: HYBIO. Form: INJECTABLE. Route: SUBCUTANEOUS

    full page →GLATIRAMER ACETATE →fda approvals ↗
    ›Feb 11, 2026approval200d agoCAMCEVI KIT (LEUPROLIDE MESYLATE) — FDA approvalForesee Pharmaceuticals Co Ltd

    Sponsor: ACCORD. Form: EMULSION. Route: SUBCUTANEOUS

    full page →fda approvals ↗
    ›Feb 11, 2026approval200d agoNARCAN (NALOXONE HYDROCHLORIDE) — FDA approvalEmergent Devices Inc

    Sponsor: EMERGENT. Form: SPRAY, METERED. Route: NASAL

    full page →fda approvals ↗
    ›Feb 11, 2026approval200d agoAUBAGIO (TERIFLUNOMIDE) — FDA approvalteriflunomide

    Sponsor: SANOFI AVENTIS US. Form: TABLET. Route: ORAL

    full page →teriflunomide →fda approvals ↗
    ›Feb 11, 2026approval200d agoGLATIRAMER ACETATE — FDA approvalGLATIRAMER ACETATE

    Sponsor: HYBIO. Form: INJECTABLE. Route: SUBCUTANEOUS

    full page →GLATIRAMER ACETATE →fda approvals ↗
    ›Feb 11, 2026approval200d agoPAXLOVID (COPACKAGED) (NIRMATRELVIR) — FDA approvalPAXLOVID (COPACKAGED)

    Sponsor: PFIZER. Form: TABLET. Route: ORAL

    full page →PAXLOVID (COPACKAGED) →fda approvals ↗
    ›Feb 11, 2026approval200d agoPAXLOVID (COPACKAGED) (NIRMATRELVIR) — FDA approvalPAXLOVID (COPACKAGED)

    Sponsor: PFIZER. Form: TABLET. Route: ORAL

    full page →PAXLOVID (COPACKAGED) →fda approvals ↗
    ›Feb 11, 2026approval200d agoBRIMONIDINE TARTRATE — FDA approvalBausch & Lomb Corp

    Sponsor: DR REDDYS LABS SA. Form: SOLUTION/DROPS. Route: OPHTHALMIC

    full page →fda approvals ↗
    ›Feb 12, 2026approval199d agoCLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER (CLINDAMYCIN PHOSPHATE) — FDA approvalCLEOCIN

    Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION

    full page →CLEOCIN →fda approvals ↗
    ← prev
    page 365 of 380
    next →
    $RDY12.18+0.16%
    $RDY12.18+0.16%
    $BLCO17.13-0.70%
    $PFE27.96-0.21%
    $RDY12.18+0.16%
    $PFE27.96-0.21%
    $PFE27.96-0.21%